- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Patrys Ltd (PAB)Patrys Ltd stock price live, this page displays ASX PAB stock exchange data. View the PAB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Patrys Ltd real time stock price chart below.
What Is the Patrys Ltd Stock Price Today?
The Patrys Ltd stock price today is 0.004.
What Is the Stock Symbol for Patrys Ltd?
The stock symbol for Patrys Ltd is "PAB."
What Stock Exchange Does Patrys Ltd Trade On?
Patrys Ltd is listed and trades on the Sydney stock exchange.
Is Patrys Ltd a Good Stock to Buy?
Determining whether Patrys Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PAB quote. (ISIN: AU000000PAB9)
What Is the Patrys Ltd Stock Price Today?
The Patrys Ltd stock price today is 0.004.
What Is the Stock Symbol for Patrys Ltd?
The stock symbol for Patrys Ltd is "PAB."
What Stock Exchange Does Patrys Ltd Trade On?
Patrys Ltd is listed and trades on the Sydney stock exchange.
Is Patrys Ltd a Good Stock to Buy?
Determining whether Patrys Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PAB quote. (ISIN: AU000000PAB9)
Sydney
Currency in AUD
0.004
0.000(0.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.004
0.004
52 wk Range
0.003
0.010
PAB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0040.004
52 wk Range
0.0030.010
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockPAB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Patrys Ltd Company Profile
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. The company dvelops Deoxymab 3E10 also called PAT-DX1 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents such as radiation and many chemotherapy drugs. In addition, it develops PAT-DX3, a full-sized antibody that has DNA-targeting properties of PAT-DX1, but different pharmaceutic properties, such as tissue distribution, pharmacokinetic profile, etc. Further, it is involved in DNA targeting, blood-brain barrier, Inhibit NETosis human therapeutic applications. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia.
Compare PAB to Peers and Sector
Metrics to compare | PAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −3.3x | −0.7x | |
PEG Ratio | −0.05 | −0.03 | 0.00 | |
Price/Book | 2.4x | 2.5x | 2.6x | |
Price / LTM Sales | 5.9x | 9.3x | 3.2x | |
Upside (Analyst Target) | - | 241.5% | 44.1% | |
Fair Value Upside | Unlock | −3.8% | 8.2% | Unlock |
FAQ
What Is the Patrys Ltd (PAB) Stock Price Today?
The Patrys Ltd stock price today is 0.004
What Stock Exchange Does Patrys Ltd Trade On?
Patrys Ltd is listed and trades on the Sydney stock exchange.
What Is the Stock Symbol for Patrys Ltd?
The stock symbol for Patrys Ltd is "PAB."
What Is the Patrys Ltd Market Cap?
As of today, Patrys Ltd market cap is 8.23M.
What is Patrys Ltd Earnings Per Share?
The Patrys Ltd EPS is -0.002.
From a Technical Analysis Perspective, Is PAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.